Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (LU-1944/3-1, EXC2151 – 390873048)
Howard Hughes Medical Institute
Bundesministerium für Bildung und Forschung (01KX2021)
Received: 20 October 2020
Accepted: 26 May 2021
First Online: 29 June 2021
: K.U.L., D.L., F.Z. and J.S.-B. are inventors on patent applications filed by the Broad Institute and others related to this work with the specific aim of ensuring that this technology can be made rapidly available for research and deployment. F.Z. is a co-founder of Editas Medicine, Beam Therapeutics, Pairwise Plants, Arbor Biotechnologies and Sherlock Biosciences. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until 31 August 2020, was a scientific advisory board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and Thermo Fisher Scientific. Since 1 August 2020, A.R. has been an employee of Genentech, a member of the Roche Group. P.H. and M.M.N. are scientific advisory board members of HMG Systems Bioengineering and receive salaries from Life & Brain. M.M.N. served on scientific advisory boards for the Lundbeck Foundation and Robert-Bosch-Stiftung, was reimbursed for travel expenses by Shire and holds shares in Life & Brain. J.D.B. is a co-founder of Coral Genomics and a scientific advisory board member of Alix Ventures.
Free to read: This content has been made available to all.